Filter Results
:
(125)
Show Results For
-
All HBS Web
(125)
- People (1)
- News (36)
- Research (70)
- Multimedia (1)
- Faculty Publications (16)
Show Results For
-
All HBS Web
(125)
- People (1)
- News (36)
- Research (70)
- Multimedia (1)
- Faculty Publications (16)
- 27 Feb 2020
- Sharpening Your Skills
How Following Best Business Practices Can Improve Health Care
Harvard Business School spends a significant amount of research funds each year on the health care industry, answering questions such as: How can the business of health care be made more efficient? What can a business do to motivate...
View Details
- 26 Jan 2015
- Research & Ideas
National Health Costs Could Decrease if Managers Reduce Work Stress
to examine such issues as adverse drug interactions and cost-effectiveness of cancer screening. "Structuring the world mathematically can lead to insights and ideas that might not be obvious," he says. Sources Of Stress For...
View Details
- 01 Dec 2003
- Research & Ideas
Sometimes Success Begins at Failure
that eventually resulted in a historic windfall for the drug maker soon after it began marketing UK-92,480 under the brand name Viagra. Pfizer was able to develop and launch a wildly successful and profitable new View Details
- 18 Dec 2018
- First Look
New Research and Ideas, December 18, 2018
2018 Innovation Policy and the Economy The Orphan Drug Act at 35: Observations and an Outlook for the Twenty-First Century By: Bagley, Nicholas, Benjamin Berger, Amitabh Chandra, Craig Garthwaite, and Ariel Dora Stern Abstract—On the 35th...
View Details
Keywords:
Dina Gerdeman
- March 2008
- Case
Novartis AG: Science-Based Business
By: H. Kent Bowen and Courtney Purrington
Novartis is a science-based drug company, which has important implications for its business strategy. It is one of the largest pharmaceutical companies in the world with over $38B in sales in 2007. Pharmaceuticals account for slightly over $24B of that total. In 2007,...
View Details
Keywords:
Innovation and Invention;
Resource Allocation;
Product Development;
Partners and Partnerships;
Research and Development;
Science-Based Business;
Pharmaceutical Industry
Bowen, H. Kent, and Courtney Purrington. "Novartis AG: Science-Based Business." Harvard Business School Case 608-136, March 2008.
- 11 Aug 2003
- Research & Ideas
Cheap, Fast, and In Control: How Tech Aids Innovation
experimentation and are triggering fundamental changes in R&D processes and performance in such fields as integrated circuit design, automotive development, and pharmaceutical drug discovery. Computer modeling and simulation, rapid...
View Details
Keywords:
by Wendy Guild
- 24 Sep 2007
- Research & Ideas
The FDA: What Will the Next 100 Years Bring?
The U.S. Food and Drug Administration, which was created by the passage of the 1906 Federal Food and Drugs Act, regulates companies and industries accounting for one-quarter of all consumer spending, roughly...
View Details
- 12 Jul 2016
- First Look
July 12, 2016
of Biosimilars: Evidence from Europe By: Scott Morton, Fiona, Ariel Dora Stern, and Scott Stern Abstract—Biologic (large-molecule) drugs represent a disproportionate and growing share of all drug View Details
Keywords:
Sean Silverthorne
- Research Summary
Health-care Applications
Active postmarketing drug surveillance. There is substantial interest within the U.S. health community and among health policymakers in developing a surveillance system that scans public health databases in order to proactively detect potential drug safety... View Details
- 02 Feb 2021
- Blog Post
Finding My Focus in Health care Amidst a Global Pandemic
I applied to the HBS and Harvard Kennedy School (HKS) MBA/MPP (Master of Public Policy) Class of 2023 to learn about the interplay between the public and private sectors in health care. Health care spending in the United States will soon...
View Details
- 05 Sep 2023
- Book
Failing Well: How Your ‘Intelligent Failure’ Unlocks Your Full Potential
In the 1990s, after drugmaker Eli Lilly spent more than a decade and millions of dollars developing the new drug Alimta to treat lung cancer, the medication came up short in effectively treating cancer in expanded trials. While the...
View Details
Keywords:
by Michael Blanding
- 22 Apr 2008
- First Look
First Look: April 22, 2008
Business Harvard Business School Case 608-136 Novartis is a science-based drug company, which has important implications for its business strategy. It is one of the largest pharmaceutical companies in the world with over $38B in sales in...
View Details
Keywords:
Martha Lagace
- Web
Great American Business Leaders of the 20th Century - Leadership
Publishing Company, 1879–1932 D C. Donald DallasRevere Copper and Brass, 1931–1947 William H. DanforthRalston Purina Company, 1894–1932 Justin DartUnited Drug Company, 1943–1980 Francis B. Davis Jr.United States Rubber Company, 1929–1942...
View Details
- 10 Oct 2007
- First Look
First Look: First Look: October 10
purchases the same customers make when shopping without a coupon. The standard permanent income or lifecycle theory of consumption predicts that grocery spending will be unaffected by the use of a $10-off coupon, while a simple mental...
View Details
Keywords:
Martha Lagace
- Web
Curriculum - Case Method Project
major infrastructure spending and fiscal crises in New York State in the first half of the 1800s, and it describes how reformers sought to address the issue of mounting public debt in the 1840s, following the Panic of 1837. In particular,...
View Details
- Web
Degrees, Certifications & Alumni Status | About
technical, analytical, and operational capabilities. MBA Program Grants: Master in Business Administration (MBA) Alumni Status: Yes The HBS MBA is a two-year general management program. Students spend their first two terms completing the...
View Details
- Web
Health Care - Faculty & Research
the treatment of a single rare disease. Objective: To estimate Medicare spending and global revenues for drugs that might have been exempt from negotiation from 2012 to 2021. Design, Setting, and...
View Details
- Web
Strategy - Faculty & Research
on psilocybin, the compound found in ‘magic mushrooms.’ Psilocybin was a federally illegal substance in the U.S., and a “Schedule I” drug, defined as a drug “with no currently accepted medical use and a high potential for abuse.” As the...
View Details
- 02 Mar 2007
- What Do You Think?
What Is the Government’s Role in US Health Care?
Newman), the high cost of new technology, artificial restrictions on the supply of drugs (Sergey Mirkiin) and healthcare providers (David Stahl and Michael Robbins), the size and complexity of the problem itself (James Sullivan),...
View Details
- 19 Dec 2017
- First Look
New Research and Ideas, December 19, 2017
is likely to have a meaningful effect on health care spending patterns. In addition, precision medicines can change the expected profitability of therapies both by allowing more sophisticated pricing systems and potentially decreasing the...
View Details
Keywords:
Carmen Nobel